Shared care follow-up after chemotherapy for testicular cancer

Shared care follow-up after chemotherapy for testicular cancer - SCFU-TC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35515

Enrollment

245

Registered

2012-08-28

Start date

2012-10-09

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testicular cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patients with disseminated testicular cancer in complete remission after chemotherapy with or without adjunctive surgery and in active follow-up * Age 18 years or older; * Started with chemotherapy after January 1st 2003; * Written informed consent.

Exclusion criteria

Exclusion criteria: * Mental disability.

Design outcomes

Secondary

Measure	Time frame
Satisfaction of participating patients, GPs and oncologists. Psychosocial well being of patients will be assessed with questionnaires (HADS, SF 36 and Distress Thermometer) when visiting their GP.	—

Primary

Measure	Time frame
The primary endpoint of this study is a safely executed follow-up within the survivorship care plan according to the pre-specified guidelines. The safety of the SCP will be evaluated by the number of failures of adequate response to the detection of relapses or cardiovascular risk factors.	—

Countries

Netherlands

Outcome results